Trajectories of Response in Patients with Moderately-to-severely Active Ulcerative Colitis Treated with Mirikizumab: Results from the LUCENT-1 Study

S. W. Schreiber, D. B. Clemow, A. Keohane,B. Zhu, T. Ritter,M. Regueiro,D. Hudesman, Y. F. Chen, C. Owen

JOURNAL OF CROHNS & COLITIS（2025）

Cited 0|Views0

AI Read Science

Must-Reading Tree

Example

Generate MRT to find the research sequence of this paper

Chat Paper

Summary is being generated by the instructions you defined